The concept of post-exposure STI prevention isn't new—it dates back to the 1940s. Unpacking interesting history at the Doxy-PEP session at #ESCMID2024 #ECCMID2024

#ECCMID is now #ESCMID who is in Barcelona, let’s catch up 👍

#LivingFreeWithHIV run in Munich 🏃‍♂️

Fast fertig für #MAIT2024 in München! 🌈✨ Beim „ #LivingFreeWithHIV “-Lauf zeigen wir Solidarität & Spaß statt Wettbewerb. Mach mit gegen HIV-Stigma! Noch nicht dabei? Melde dich hier an: my.raceresult.com/267876/registr… 🏃‍♂️🏃‍♀️ Treffen wir uns am 23.03.2024! Deutsche Aidshilfe GSSG

Availability of Cabotegravir PrEP #CROI2024 Dr. Rupa Patel

6.2 million cumulative PrEP starts over 12 years #CROI2024 Dr. Rupa Patel

Generics of Cabotegravir PrEP is available 2027 BUT “We must have parallel scientific discovery and regulatory efforts for earlier and shorter timelines for generic product access!!” ✊ #CROI2024

First data from trial of once-weekly oral #HIV treatment. Amy Colson (Community Resource Initiative) reports 94% of people on islatravir+lenacapavir maintained viral suppression. Could be 1st long-acting tx that doesn't involve injections. Merck Gilead Sciences #CROI2024
aidsmap.com/news/mar-2024/…

Phase II study reveals weekly oral Islatravir (2mg) + Lenacapavir (300mg) maintains high virologic suppression (94.2%) at 24 weeks without CD4 count decrease in PLWHIV #CROI2024

New study reveals long-acting formulations of lopinavir may not require ritonavir boosting, offering simpler, more efficient drug delivery. A game-changer for global HIV management. #CROI2024

#LA -CAB/RPV подтвердил эффективность у людей с неподавленным #ВИЧ #CROI2024 #CAB #RPV life4me.plus/ru/news/la-cab…

Длительное исследование, проведённое в Африке, подтвердило эффективность инъекционной схемы каботегравир/рилпивирин: комбинация оказалась такой же эффективной, как и стандартная #АРТ #ВИЧ #Каботегравир #Рилпивирин #CROI2024 life4me.plus/ru/news/inekts…

Please sign: Centering LGBTQ+ Rights at CROI chng.it/Wq9h84Ks via Change.org

#CROI2024 focus on risk may exacerbate disparities which is why shift from risk-based decisions to offer PrEP to anyone who may benefit in the CDC guidelines was so important.
We must use PrEP lessons to guide DoxyPEP use while remembering there are important differences!

New SEARCH randomized trial results: Person-centered HIV prevention increases coverage by 30-40% over standard care in Kenya & Uganda. Dynamic choices between CAB-LA, oral PrEP & PEP key to success. Zero new HIV cases in intervention group vs 1.8% in control. #CROI2024

Come on @AIDS_journal! As @tristanjbarber1 has rightly pointed out on LinkedIn 'HIV-infected infant' is not OK terminology. I invite you again to join The Lancet HIV (indeed the whole @TheLancet journal portfolio) & HIV Medicine in endorsing PeopleFirstCharter please 🙏

Исследование показало, что комбинация из 3 антител обеспечивает долгосрочный вирусологический контроль у людей, живущих с ВИЧ. #ВИЧ #Антитела #bNAbs #CROI2024 life4me.plus/ru/news/antite…